Low-Energy X-Ray Intraoperative Radiation Therapy (Lex-IORT) for Resected Brain Metastases: A Single-Institution Experience.

Autor: Diehl, Christian D.^1,2,3 (AUTHOR) christian.diehl@tum.de, Pigorsch, Steffi U.^1,2,3 (AUTHOR), Gempt, Jens⁴ (AUTHOR), Krieg, Sandro M.^4,5 (AUTHOR), Reitz, Silvia¹ (AUTHOR), Waltenberger, Maria¹ (AUTHOR), Barz, Melanie⁴ (AUTHOR), Meyer, Hanno S.⁴ (AUTHOR), Wagner, Arthur⁴ (AUTHOR), Wilkens, Jan¹ (AUTHOR), Wiestler, Benedikt⁶ (AUTHOR), Zimmer, Claus⁶ (AUTHOR), Meyer, Bernhard⁴ (AUTHOR), Combs, Stephanie E.^1,2,3 (AUTHOR)

Publikováno v: Cancers. Jan2023, Vol. 15 Issue 1, p14. 12p.

MRI- and CT-determined changes of dysphagia / aspiration-related structures (DARS) during and after radiotherapy.

Autor: Pigorsch, Steffi U.¹ (AUTHOR) steffi.pigorsch@tum.de, May, Chaline¹ (AUTHOR), Kessel, Kerstin A.^1,2 (AUTHOR), Graf, Simone³ (AUTHOR), Bier, Henning³ (AUTHOR), Nüsslin, Fridtjof¹ (AUTHOR), Waschulzik, Birgit⁴ (AUTHOR), Combs, Stephanie E.^1,2 (AUTHOR)

Publikováno v: PLoS ONE. 9/2/2020, Vol. 15 Issue 9, p1-16. 16p.

Report on planning comparison of VMAT, IMRT and helical tomotherapy for the ESCALOX-trial pre-study

Autor: Pigorsch, Steffi U, Kampfer, Severin, Oechsner, Markus, Mayinger, Michael C, Mozes, Petra, Devecka, Michal, Kessel, Kerstin K, Combs, Stephanie E, Wilkens, Jan J

Publikováno v: Radiat. Oncol. 15:253 (2020)
Radiation Oncology, Vol 15, Iss 1, Pp 1-10 (2020)
Radiation Oncology (London, England)

Background: The ESCALOX trial was designed as a multicenter, randomized prospective dose escalation study for head and neck cancer. Therefore, feasibility of treatment planning via different treatment planning systems (TPS) and radiotherapy (RT) tech

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19f044fe1e14840a8677732ea33d0e39
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=60470

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Comparison of neoadjuvant chemoradiation with carboplatin/ paclitaxel or cisplatin/ 5-fluoruracil in patients with squamous cell carcinoma of the esophagus.

Autor: Münch, Stefan^1,2 stefan.muench@mri.tum.de, Pigorsch, Steffi U.^1,2, Feith, Marcus³, Slotta-Huspenina, Julia⁴, Weichert, Wilko^2,4, Friess, Helmut³, Combs, Stephanie E.^1,2,5, Habermehl, Daniel^1,2,5 daniel.habermehl@tum.de

Publikováno v: Radiation Oncology. 11/21/2017, p1-10. 10p.